Antibody-directed enzyme prodrug therapy (ADEPT): a review

This publication has 83 references indexed in Scilit:

• Poly(ethylene glycol)-Doxorubicin Conjugates Containing .beta.-Lactamase-Sensitive Linkers
  Bioconjugate Chemistry, 1995
• Tumour regressions with novel prodrugs in antibody-directed enzyme prodrug therapy (ADEPT)
  European Journal Of Cancer, 1994
• Novel analogues of CB 1954: Their potential use in antibody directed enzyme prodrug therapy (ADEPT)
  European Journal Of Cancer, 1994
• Tumor targeting: Activation of prodrugs by enzyme-monoclonal antibody conjugates
  Trends in Biotechnology, 1994
• Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate
  Cancer Immunology, Immunotherapy, 1992
• Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds
  European Journal of Cancer and Clinical Oncology, 1991
• Activation of Methotrexate Prodrugs by Enzyme/Monoclonal Antibody Conjugates
  Pteridines, 1991
• Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide
  Cancer Immunology, Immunotherapy, 1990
• Selective Cytotoxicity of Carboxypeptidase-activated Methotrexate ex-Peptides
  Pteridines, 1989
• CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells
  Biochemical and Biophysical Research Communications, 1986